The Physalis Child : Identification of Cognitive and Emotional Factors

NCT ID: NCT02567500

Last Updated: 2018-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-07

Study Completion Date

2017-07-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to show presence of cognitive and emotional factors on the beginning and persistence of auditory hallucinations in non-psychotic children. Investigators will describe a significant link between this factors and hallucinations in a sample of non-psychotic children. The results of this sample will be comparing to another group of children of the same age, sex and diagnosis, but without hallucination. Finally, investigators will control the persistence of hallucination on the first group after a six month period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Hallucinations are a common symptom in pediatric population without psychotic syndrome. Vulnerability, co morbidity and risk factor are already been described. Investigators will study the cognitive and emotional factors on the beginning and persistence of auditory hallucinations in non-psychotic children. The goal of the study is to find a social cognition our emotional impairment to explain auditory hallucinations without psychotic symptoms. Methods: Sample of out non-psychotic patients aged six to eighteen years old with auditory hallucinations were recruited with a self report scale created for this study. Mini International Neuropsychiatric Interview (MINI)-kids interview and "psychosis" section od Kiddie-SADS (Schedule for Affective Disorders and Schizophrenia for school age chidlren) were conducted to determine Diagnostic and Statistical Manual of Mental Disorders (DSM) IV diagnoses. All children patient were spend specifics social cognition (NeuroPsychologic assessment NEPSY II) and emotional (ifferential Emotions Scale (DES) IV, Beliefs About Voices Questionnaire Revised (BAVQ-R)) scales. Each child results will be compared to child result of the same age, sex and diagnosis but without hallucination that passed the same specifics scales. All of child will be control after a six month period to evaluate auditory hallucination persistence and diagnosis evolution. The total period of the study will be twelve month.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Auditory Hallucinations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with auditory hallucination

Patients with auditory hallucination:

Evaluation at time 0 and 6 month after of:

* The social cognitive marker (NeuroPsychologic assessment (NEPSY) II) : theory of mind and affect recognition
* The emotional marker:

* Differential Emotion Scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with Diagnostic and Statistical Manual of Mental Disorders (DSM) -IV criteria:

* Mini International Neuropsychiatric Interview (MINI) -Kids
* "Psychosis" section of Kiddie-SADS

Group Type EXPERIMENTAL

Patients with auditory hallucination

Intervention Type BEHAVIORAL

Patients with auditory hallucination (20 for each arm):

Evaluation at time 0 and 6 month after of:

* The social cognitive marker (NEPSY II) : theory of mind and affect recognition
* The emotional marker:

* Differential emotion scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with DSM-IV criteria:

* MINI-Kids
* "Psychosis" section of Kiddie-SADS

Patients without auditory hallucination

Patients without auditory hallucination:

Evaluation at time 0 and 6 month after of:

* The social cognitive marker (NEPSY II) : theory of mind and affect recognition
* The emotional marker:

* Differential emotion scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with Diagnostic and Statistical Manual of Mental Disorders (DSM) -IV criteria:

* Mini International Neuropsychiatric Interview (MINI) -Kids
* "Psychosis" section of Kiddie-SADS (Schedule for Affective Disorders and Schizophrenia )

Group Type PLACEBO_COMPARATOR

Patients without auditory hallucination

Intervention Type BEHAVIORAL

Patients without auditory hallucination (20 for each arm):

Evaluation at time 0 and 6 month after of:

* The social cognitive marker (NEPSY II) : theory of mind and affect recognition
* The emotional marker:

* Differential emotion scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with DSM-IV criteria:

* MINI-Kids
* "Psychosis" section of Kiddie-SADS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patients with auditory hallucination

Patients with auditory hallucination (20 for each arm):

Evaluation at time 0 and 6 month after of:

* The social cognitive marker (NEPSY II) : theory of mind and affect recognition
* The emotional marker:

* Differential emotion scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with DSM-IV criteria:

* MINI-Kids
* "Psychosis" section of Kiddie-SADS

Intervention Type BEHAVIORAL

Patients without auditory hallucination

Patients without auditory hallucination (20 for each arm):

Evaluation at time 0 and 6 month after of:

* The social cognitive marker (NEPSY II) : theory of mind and affect recognition
* The emotional marker:

* Differential emotion scale IV (DES IV): emotional individual stability
* Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination.
* Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria.
* Evaluation of diagnosis with DSM-IV criteria:

* MINI-Kids
* "Psychosis" section of Kiddie-SADS

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Twenty participants included with auditory hallucination:

* Boy or girl
* French
* Over six years old and under eighteen years old
* DSM-IV diagnosis of mood disorder, anxiety, disruptive behavioral disorder, attention deficit hyperactivity disorder, without schizophrenia diagnosis, without mental retardation (Intelligence Quotient (IQ)\>70),
* Parental and child consent, affiliated to social security.
* Twenty participants included without auditory hallucination:

* Boy or girl
* French,
* Over six years old and under eighteen years old
* DSM-IV diagnosis of mood disorder, anxiety, disruptive behavioral disorder, attention deficit hyperactivity disorder, without schizophrenia diagnosis, without mental retardation (IQ\>70)
* Parental and child consent, affiliated to social security.

Exclusion Criteria

* schizophrenia diagnosis,
* neurologic, genetic or neurosensory disorders
Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation Lenval

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Valérie BONNARD-COUTON, MD

Role: PRINCIPAL_INVESTIGATOR

Fondation Lenval

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fondation Lenval

Nice, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Dumas LE, Bonnard-Couton V, Golse B, Askenazy F. [Identifying cognitive and emotional markers in relation to auditory-verbal hallucinations in pediatric population: Physalis study]. Encephale. 2022 Oct;48(5):546-554. doi: 10.1016/j.encep.2021.06.010. Epub 2021 Oct 5. French.

Reference Type DERIVED
PMID: 34625214 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14-HPNCL-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phosphatidylcholine Supplementation in Infants
NCT01905605 WITHDRAWN PHASE1/PHASE2